The pharmacological rationale for combining muscarinic receptor antagonists and β-adrenoceptor agonists in the treatment of airway and bladder disease()

Muscarinic receptor antagonists and β-adrenoceptor agonists are used in the treatment of obstructive airway disease and overactive bladder syndrome. Here we review the pharmacological rationale for their combination. Muscarinic receptors and β-adrenoceptors are physiological antagonists for smooth m...

Descripción completa

Detalles Bibliográficos
Autores principales: Dale, Philippa R, Cernecka, Hana, Schmidt, Martina, Dowling, Mark R, Charlton, Steven J, Pieper, Michael P, Michel, Martin C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Ltd 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071415/
https://www.ncbi.nlm.nih.gov/pubmed/24682092
http://dx.doi.org/10.1016/j.coph.2014.03.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4071415/
https://www.ncbi.nlm.nih.gov/pubmed/24682092
http://dx.doi.org/10.1016/j.coph.2014.03.003

Ejemplares similares